COVID-19

  • Pandemic Response: Maintaining Effective and Safe IV Infusion Therapy

    Pandemic Response: Maintaining Effective and Safe IV Infusion Therapy for Critically Ill and Isolated Patients Lisa Gangol. RN, BSN. Beckton Dickinson. Senior Clinical Resource Consultant. Medication Management Solutions. Eastern Europe, Middle East & Africa. Natalie Samuda. RM, BSc. Becton Dickinson. Senior Clinical Resource Consultant. Medication Management Solutions. Eastern Europe, Middle East & Africa. James Waterson. RN, M.Med.Ed. Becton Dickinson. Medication…

    Read More »
  • The Ethics Committee of Hôtel-Dieu de France During the COVID-19 Pandemic

      Hôtel-Dieu de France’s Ethics Committee is composed of health professionals and people of moral authority (academics, religious, lawyers, social workers, civil society members, etc.). The Committee meets once a month or more, in case of emergencies, to discuss with doctors and health professionals and advise them in order to make the best decision and offer their patients the best…

    Read More »
  • Information exchange during COVID-19: Lifesaving Data

    By Dr. Bakr Sadoon Ismael, Ambulatory Healthcare Services Co, a SEHA System Facility Member of the Clinical Advisory Committee of Malaffi The key theme for the 2020 World Allergy Week of ‘COVID-19 and allergy’ has generated a lot of debate within the global healthcare community. According to the World Allergy Organization (WAO), discussions for the week will focus on the…

    Read More »
  • GILEAD SCIENCES ANNOUNCES APPROVAL OF VEKLURY® (REMDESIVIR) IN UAE FOR PATIENTS WITH SEVERE COVID-19

    GILEAD SCIENCES ANNOUNCES APPROVAL OF VEKLURY® (REMDESIVIR) IN THE UNITED ARAB EMIRATES FOR PATIENTS WITH SEVERE COVID-19 Gilead Sciences, Inc. (Nasdaq: GILD) announced that the United Arab Emirates’ Ministry of Health and Prevention has granted regulatory approval of Veklury® (remdesivir) as an Emergency Medicine for treatment of SARS-CoV-2 infection, the virus that causes COVID-19. The regulatory approval is supported by…

    Read More »
  • Boehringer Ingelheim held a regional media webinar titled ‘Managing Type 2 Diabetes during COVID-19’

    COVID-19 and Type 2 diabetes: Regional experts shed light on the latest scientific updates and clinical practices in disease management for patient education With 39 million people living with diabetes in the Middle East and North Africa, it is of crucial importance to educate individuals with this pre-existing medical condition on disease management during COVID-19 Boehringer Ingelheim presents a digital…

    Read More »
  • Boehringer Ingelheim Teams Up with the Lebanese Pulmonary Society (LPS) in its Fight against COVID-19

    In joining the fight to reduce the vast spread of COVID-19 virus, Boehringer Ingelheim, Lebanon has donated medical supplies to the Lebanese Pulmonary Society (LPS).  The move comes in the framework of the Global Support Program launched by the company back in April and that aims at bringing financial relief and donating protective materials and medicine to healthcare institutions and…

    Read More »
  • Global healthcare community to unite in world’s biggest virtual event Omnia Health Live

    For five days in June (22-26 June 2020) the global healthcare community will be brought together on a scale like never seen before through a new experience delivered entirely online, Omnia Health Live. The virtual event is brought by Informa Markets Healthcare, organiser of world-leading events Arab Health, Hospitalar, FIME and Medlab Middle East. Omnia Health Live answers the needs…

    Read More »
  • WCM-Q faculty publish lessons for humanity after COVID-19

    Faculty at Weill Cornell Medicine – Qatar (WCM-Q) have collated information about the novel coronavirus – and suggested lessons that humanity could learn from the current crisis. Led by Dr. Ali Sultan professor of microbiology and immunology at WCM-Q, the team worked with colleagues at Qatar’s Ministry of Public Health to gather known facts about the virus’ epidemiology, individual countries’…

    Read More »
  • HDF Crisis Management in the Face of COVID-19

      One in ten patients in the world is a doctor or a healthcare worker. To ensure their protection and to welcome its patients, Hôtel-Dieu de France has implemented a crisis management plan in response to the situation on the ground in the face of the coronavirus pandemic. Since March 1 and upon the request of the Lebanese authorities, HDF…

    Read More »
  • Department of Health: Abu Dhabi further strengthens response to COVID-19 through Malaffi

    In an effort to further reinforce the response to COVID-19, and under the direction of the Department of Health – Abu Dhabi (DOH), Malaffi, the region’s first Health Information Exchange (HIE) platform, has announced the urgent release of two solutions, to provide urgent extended access to Malaffi and a centralised database of all COVID-19 testing results in real-time. These solutions…

    Read More »
Back to top button